| Code | 23093 | ||||||||||
| MA number | 29/0110/06-S | ||||||||||
| Product Form: | tbl flm 100x400 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 10.02.2006 |
| Pediatric posology: | Yes |
| SPC: |
SPC_BRUFEN 400 mg_04.2024.pdf
|
| PIL: |
PIL_BRUFEN 400 mg_Rx_04.2024.pdf
|
| PIL: |
PIL_BRUFEN 400 mg_OTC_04.2024.pdf
|
| Safety feature | Unknown |
| Data update: | 29.11.2022 |
